Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Chemodex
Piperlongumine (natural)
As low as
361
CHF
CHF 361.00
In stock
Only %1 left
CDX-P0921-M250250 mgCHF 361.00
CDX-P0921-M500500 mgCHF 541.00
NEW

Product Details | |
---|---|
Synonyms | Piplartine; 5,6-Dihydro-1-(1-oxo-3-[3,4,5-trimethoxyphenyl]-trans-2-propenyl)-2[1H]-pyridinone |
Product Type | Chemical |
Properties | |
Formula | C17H19NO5 |
MW | 317.34 |
CAS | 20069-09-4 |
RTECS | UU7785850 |
Source/Host Chemicals | Plant |
Purity Chemicals | ≥98% (HPLC) |
Appearance | White to off-white powder. |
Solubility | Soluble in DMSO or DMF (both 20mg/ml). |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by Chemodex. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
InChi Key | VABYUUZNAVQNPG-BQYQJAHWSA-N |
Smiles | O=C1N(C(/C=C/C2=CC(OC)=C(OC)C(OC)=C2)=O)CCC=C1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +20°C |
Long Term Storage | +4°C |
Handling Advice | Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
Piperlongumine is a cell-permeable, orally bioavailable natural product isolated from the plant species, Piper longum L, which selectively induces cell death in cancer cells that express both wild-type and mutant p53 but not in primary normal cells and non-transformed immortalized cells. Piperlongumine enhances wild-type p53 and PUMA expression, and inhibits the expression of several pro-survival proteins, including BCL2, surviving, and XIAP, in various types of cancer cells, but not in normal cells. It induces ROS and apoptosis in several human cancer cells (EJ, MDA-MB-231, U2OS and MDA-MB-435), possibly through interaction with oxidative stress responders such as GSTP1 and CBR1. Additionally, it exhibits anti-tumour effects and inhibits the formation of blood vessels in xenograft-tumour mice and inhibits tumor growth and their associated metastases in a MMTV-PyVT breast cancer transgenic mouse model (2.4mg/kg, daily for two weeks, i.p.). Piperlongumine possesses ant-inflammatory, antibacterial, antiangiogenic, antioxidant, anticancer, antiplatelet, anxiolytic, antidepressant and antidiabetic activities.
Product References
(1) A. Chatterjee & C.P Dutta; Tetrahedron 23, 1769 (1967) | (2) C.Y. Duh, et al.; J. Nat. Prod. 53, 1575 (1990) | (3) D.P. Bezerra, et al.; Z. Naturforsch. C 60, 539 (2005) | (4) D.P. Bezerra, et al.; Toxicol. In Vitro 21, 1 (2007) | (5) M. Iwashita, et al.; Eur. J. Pharmacol. 570, 38 (2007) | (6) F.F. C�cero Bezerra, et al.; Phytomedicine 14, 605 (2007) | (7) H. Zhang, et al.; Bioorg. Med. Chem. Lett. 18, 3272 (2008) | (8) E.H. Kong, et al.; Oncol. Rep. 20, 785 (2008) | (9) J.B. Fontenele, et al.; J. Pharm. Pharmacol. 61, 511 (2009) | (10) L. Raj, et al.; Nature 475, 231 (2011) | (11) J. Moraes, et al.; Exp. Parasitol. 127, 357 (2011) | (12) K.V. Golovine, et al.; Prostate 73, 23 (2013) | (13) J. Zheng, et al.; Sci. Rep. 6, 26357 (2016) | (14) W. Harshbarger, et al.; J. Biol. Chem. 292, 112 (2017) | (15) E. Bosc, et al.; BBRC 496, 961 (2018) | (16) P. Xu, et al.; J. Biochem. Mol. Toxicol. 35, 1 (2021)